Publication

Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Nicholas L Johnson, University of Texas Medical School at HoustonCharles E Wade, University of Texas Medical School at HoustonErin E Fox, University of Texas Medical School at HoustonDavid E Meyer, University of Texas Medical School at HoustonCharles J Fox, University of Colorado School of MedicineErnest E Moore, University of Colorado School of MedicineJonathan Morrison, University of Maryland School of MedicineThomas Scalea, University of Maryland, Baltimore (UMB)Elieen M Bulger, University of WashingtonKenji Inaba, Keck School of Medicine of USCBryan Morse, Emory UniversityLaura J Moore, University of Texas Medical School at Houston
Language
  • English
Date
  • 2021-02-23
Publisher
  • Emory University Libraries
Publication Version
Copyright Statement
  • © Author(s) (or their employer(s)) 2021.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 6
Issue
  • 1
Grant/Funding Information
  • The Emergent Truncal Hemorrhage Control Study was sponsored by Prytime Medical Devices, Inc., through a contract with the US Department of Defense (W911QY-15-C0099).
Abstract
  • Background Non-compressible truncal hemorrhage (NCTH) is the leading cause of preventable death after trauma. Resuscitative endovascular balloon occlusion of the aorta (REBOA) achieves temporary hemorrhage control, supporting cardiac and cerebral perfusion prior to definitive hemostasis. Aortic zone selection algorithms vary among institutions. We evaluated the efficacy of an algorithm for REBOA use. Methods A multicenter prospective, observational study conducted at six level 1 trauma centers over 12 months. Inclusion criteria were age >15 years with evidence of infradiaphragmatic NCTH needing emergent hemorrhage control within 60 min of ED arrival. An algorithm characterized by the results of focused assessment with sonography in trauma and pelvic X-ray was assessed post hoc for efficacy in a cohort of patients receiving REBOA. Results Of the 8166 patients screened, 78 patients had a REBOA placed. 21 patients were excluded, leaving 57 patients for analysis. The algorithm ensures REBOA deployment proximal to hemorrhage source to control bleeding in 98.2% of cases and accurately predicts the optimal REBOA zone in 78.9% of cases. If the algorithm was violated, bleeding was optimally controlled in only 43.8% (p=0.01). Three (75.0%) of the patients that received an inappropriate zone 1 REBOA died, two from multiple organ failure (MOF). All three patients that died with an inappropriate zone 3 REBOA died from exsanguination. Discussion This algorithm ensures proximal hemorrhage control and accurately predicts the primary source of hemorrhage. We propose a new algorithm that will be more inclusive. A zone 3 REBOA should not be performed when a zone 1 is indicated by the algorithm as 100% of these patients exsanguinated. MOF, perhaps from visceral ischemia in patients with an inappropriate zone 1 REBOA, may have been prevented with zone 3 placement or limited zone 1 occlusion time. Level of evidence Level III.
Author Notes
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items